Columbia University Irving Medical Center has secured a leading role in a major US biomedical research initiative, helping coordinate the data infrastructure behind the National Heart, Lung, and Blood Institute’s (NHLBI) Super Intelligence Initiative. The program aims to accelerate discoveries that could lead to treatments for several major categories of disease.
According to Columbia University Irving Medical Center, the initiative brings together extensive biomedical datasets and artificial intelligence (AI) to improve understanding of heart, lung, blood and sleep disorders and identify new possibilities for therapy.
Columbia builds data hub
Researchers Elizabeth Oelsner and R. Graham Barr will lead Columbia’s contribution by creating the Precision Medicine Epidemiology Center. It will function as the initiative’s data coordinating center, overseeing research data and helping establish consistent methods across participating studies.
More than 20 co-investigators from Columbia and partner organizations will contribute. The center will also advise researchers on study design and procedures for gathering data in new AI-supported investigations.
Experience at scale
The selection builds on Columbia’s work assembling research participant groups, coordinating studies across institutions and standardizing biomedical information. Its researchers have applied deep learning to harmonize data from more than 125,000 lung and cardiac CT scans.
Columbia will also hold a broader leadership position, joining the initiative’s Scientific Leadership Committee alongside researchers from Stanford University and Vanderbilt University Medical Center.
Why it matters
The project places Columbia at the center of an effort to connect large-scale health data with AI-driven discovery. Its coordinating role could help researchers work across datasets and institutions more consistently. The next important development will be how the center supports new studies and helps turn biomedical data into potential therapeutic targets.